Strength
25 mg/1
Manufacturer
Cipla USA Inc.NDC
69097051607
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
2/18/2026
Active Ingredients
CYCLOPHOSPHAMIDEApproval Type
Generic (ANDA)
FDA Application
ANDA211608On Market Since
1/18/2019
Related Drugs
Same classification
No related drugs found.